Mlpharms Ltd
07274054
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/03/2026
total exemption full
Next accounts due
31/12/2027
Confirmation statement
Last: 15/07/2026
Due 29/07/2027
Industry
Officers
Persons with Significant Control
Mr Mark Llewellyn
British · England
Notified 06/04/2016
Mrs Caroline Jane Llewellyn
British · England
Notified 06/04/2016
CompanyRankvs 189+ SIC 64303 peers74
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2026
Net Worth
£31k
Balance sheet strength
Cash
£28k
Cash in the bank
Net Current Assets
£29k
Working capital
Current Assets
£29k
Current Liabilities
£160
Fixed Assets
£3k
Debtors
£2k
Director Loans(2024)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2026 | 182.28 | -£24k |
| 2025 | 1.08 | +£49k |
| 2024 | 1.01 | -£2k |
Derived from filed accounts. Not audited figures.